Teva Pharmaceutical Industries TEVA
NYSE TEVA
$39.53 +0.20 (+0.51%)
At close: Oct 2, 2026 · 4:00 PM EDT

Teva Pharmaceutical Industries (TEVA) Cash from Investing Activities (2009 - 2026)

Updated

Teva Pharmaceutical Industries (TEVA) reported Cash from Investing Activities of -$491 million for Q2 2026, compared with $236 million a year earlier.

Analysis

Teva Pharmaceutical Industries (TEVA) Cash from Investing Activities (2009 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Teva Pharmaceutical Industries' Cash from Investing Activities came in at $38 million, down 95.8% year-over-year; for FY2025, it was $737 million, down 6.9% from FY2024.

  • Cash from Investing Activities has a five-year compound annual growth rate of -3.1% (FY2020 to FY2025).
  • By year, Cash from Investing Activities came in at $792 million in FY2024 (-18.2%), $968 million in FY2023 (+47.6%), $656 million in FY2022 (-56.9%) and $1.52 billion in FY2021 (+76.5%).
  • The Q2 2026 figure ranks as the lowest quarterly Cash from Investing Activities since Q3 2016.
  • Year over year, Cash from Investing Activities gained in four of the last seven quarters, with growth averaging 4.4%.
  • The high point for year-over-year Cash from Investing Activities in five years was Q3 2021 (growth of 83.4%); the low point was Q1 2022 (a decline of 68.3%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $229 million (Q1 2026), $165 million (Q4 2025) and $135 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -15.40 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn -1.11 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -1.20 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -5.60 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -3.11 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -2.91 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -569.00 Mn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -10.35 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 2.11 Bn
10 Teva Pharmaceutical Industries 46.06 Bn 32.91 Bn 2.15 Bn -491.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -491.00 Mn
Mar 31, 2026 229.00 Mn
Dec 31, 2025 165.00 Mn
Sep 30, 2025 135.00 Mn
Jun 30, 2025 236.00 Mn
Mar 31, 2025 201.00 Mn
Dec 31, 2024 202.00 Mn
Sep 30, 2024 268.00 Mn
Jun 30, 2024 178.00 Mn
Mar 31, 2024 144.00 Mn
Dec 31, 2023 301.00 Mn
Sep 30, 2023 184.00 Mn
Jun 30, 2023 302.00 Mn
Mar 31, 2023 181.00 Mn
Dec 31, 2022 168.00 Mn
Sep 30, 2022 147.00 Mn
Jun 30, 2022 179.00 Mn
Mar 31, 2022 161.00 Mn
Dec 31, 2021 246.00 Mn
Sep 30, 2021 288.00 Mn
API Access

Teva Pharmaceutical Industries Cash from Investing Activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-investing-activities&ticker=TEVA&period=max&api_key=YOUR_API_KEY